FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

407097007: Bortezomib (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2004. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2150927017 Bortezomib (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
2158720013 Bortezomib en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Bortezomib Is a Antineoplastic agent false Inferred relationship Existential restriction modifier
Bortezomib Is a Substance with proteasome inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Bortezomib Has disposition Proteasome inhibitor true Inferred relationship Existential restriction modifier
Bortezomib Is a Immunologic agent true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Bortezomib 3.5mg lyophilized powder for injection Has active ingredient False Bortezomib Inferred relationship Existential restriction modifier
Velcade 3.5mg lyophilized powder for injection Has active ingredient False Bortezomib Inferred relationship Existential restriction modifier
Product containing bortezomib Has active ingredient True Bortezomib Inferred relationship Existential restriction modifier 1
Bortezomib Has active ingredient True Bortezomib Inferred relationship Existential restriction modifier 1
Product containing bortezomib in parenteral dose form (medicinal product form) Has active ingredient True Bortezomib Inferred relationship Existential restriction modifier 1
Product containing only bortezomib in parenteral dose form (medicinal product form) Has active ingredient True Bortezomib Inferred relationship Existential restriction modifier 1
Product containing precisely bortezomib 3.5 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has basis of strength substance True Bortezomib Inferred relationship Existential restriction modifier 1
Product containing precisely bortezomib 3.5 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has precise active ingredient True Bortezomib Inferred relationship Existential restriction modifier 1
Bortezomib 2.5mg powder for solution for injection vials (Pfizer Ltd) Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 3.5mg powder for solution for injection vials (medac UK) 1 vial Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 2.5mg powder for solution for injection vials (Pfizer Ltd) 1 vial Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 3.5mg powder for solution for injection vials (Pfizer Ltd) Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 3.5mg powder for solution for injection vials (medac UK) Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 3.5mg powder for solution for injection vials (Pfizer Ltd) 1 vial Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 3.5mg powder for solution for injection vials (Sandoz Ltd) Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 3.5mg powder for solution for injection vials (Sandoz Ltd) 1 vial Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 3.5mg/1.4ml solution for injection vials (Accord Healthcare Ltd) Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 3.5mg/1.4ml solution for injection vials (Accord Healthcare Ltd) 1 vial Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 3.5mg powder for solution for injection vials (Aspire Pharma Ltd) Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 3.5mg powder for solution for injection vials (Aspire Pharma Ltd) 1 vial Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 3.5mg powder for solution for injection vials (Dr Reddy's Laboratories (UK) Ltd) 1 vial Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 3.5mg powder for solution for injection vials (Dr Reddy's Laboratories (UK) Ltd) Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 2.75mg/1.1ml in Sodium chloride 0.9% solution for injection pre-filled syringes Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 2.25mg/0.9ml in Sodium chloride 0.9% solution for injection pre-filled syringes Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 2mg/0.8ml in Sodium chloride 0.9% solution for injection pre-filled syringes Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 1.6mg/0.64ml in Sodium chloride 0.9% solution for injection pre-filled syringes Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 1.8mg/0.72ml in Sodium chloride 0.9% solution for injection pre-filled syringes Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 3mg/1.2ml in Sodium chloride 0.9% solution for injection pre-filled syringes Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 2.5mg/1ml in Sodium chloride 0.9% solution for injection pre-filled syringes Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 2.5mg/1ml in Sodium chloride 0.9% solution for injection pre-filled syringes (Special Order) Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 1.6mg/0.64ml in Sodium chloride 0.9% solution for injection pre-filled syringes 1 pre-filled disposable injection Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 1.6mg/0.64ml in Sodium chloride 0.9% solution for injection pre-filled syringes (Special Order) Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 1.8mg/0.72ml in Sodium chloride 0.9% solution for injection pre-filled syringes (Special Order) 1 pre-filled disposable injection Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 1.8mg/0.72ml in Sodium chloride 0.9% solution for injection pre-filled syringes Has active ingredient False Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 1.6mg/0.64ml in Sodium chloride 0.9% solution for injection pre-filled syringes Has active ingredient False Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 2.75mg/1.1ml in Sodium chloride 0.9% solution for injection pre-filled syringes (Special Order) Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 2mg/0.8ml in Sodium chloride 0.9% solution for injection pre-filled syringes (Special Order) 1 pre-filled disposable injection Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 2.25mg/0.9ml in Sodium chloride 0.9% solution for injection pre-filled syringes Has active ingredient False Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 1.8mg/0.72ml in Sodium chloride 0.9% solution for injection pre-filled syringes 1 pre-filled disposable injection Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 2.5mg/1ml in Sodium chloride 0.9% solution for injection pre-filled syringes Has active ingredient False Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 3mg/1.2ml in Sodium chloride 0.9% solution for injection pre-filled syringes (Special Order) Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 3mg/1.2ml in Sodium chloride 0.9% solution for injection pre-filled syringes 1 pre-filled disposable injection Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 2.25mg/0.9ml in Sodium chloride 0.9% solution for injection pre-filled syringes (Special Order) Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 3mg/1.2ml in Sodium chloride 0.9% solution for injection pre-filled syringes (Special Order) 1 pre-filled disposable injection Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 2mg/0.8ml in Sodium chloride 0.9% solution for injection pre-filled syringes 1 pre-filled disposable injection Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 2.5mg/1ml in Sodium chloride 0.9% solution for injection pre-filled syringes 1 pre-filled disposable injection Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 2.75mg/1.1ml in Sodium chloride 0.9% solution for injection pre-filled syringes Has active ingredient False Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 2mg/0.8ml in Sodium chloride 0.9% solution for injection pre-filled syringes (Special Order) Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 1.6mg/0.64ml in Sodium chloride 0.9% solution for injection pre-filled syringes (Special Order) 1 pre-filled disposable injection Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 2.25mg/0.9ml in Sodium chloride 0.9% solution for injection pre-filled syringes (Special Order) 1 pre-filled disposable injection Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 2.25mg/0.9ml in Sodium chloride 0.9% solution for injection pre-filled syringes 1 pre-filled disposable injection Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 2.5mg/1ml in Sodium chloride 0.9% solution for injection pre-filled syringes (Special Order) 1 pre-filled disposable injection Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 1.8mg/0.72ml in Sodium chloride 0.9% solution for injection pre-filled syringes (Special Order) Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 2.75mg/1.1ml in Sodium chloride 0.9% solution for injection pre-filled syringes (Special Order) 1 pre-filled disposable injection Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 2.75mg/1.1ml in Sodium chloride 0.9% solution for injection pre-filled syringes 1 pre-filled disposable injection Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 3mg/1.2ml in Sodium chloride 0.9% solution for injection pre-filled syringes Has active ingredient False Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 2mg/0.8ml in Sodium chloride 0.9% solution for injection pre-filled syringes Has active ingredient False Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 3.5mg powder for solution for injection vials Has active ingredient False Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 3.5mg/1.4ml solution for injection vials Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 3.5mg/1.4ml solution for injection vials Has active ingredient False Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 3.5mg/1.4ml solution for injection vials (Thornton & Ross Ltd) Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 3.5mg/1.4ml solution for injection vials 1 vial Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 3.5mg/1.4ml solution for injection vials (Thornton & Ross Ltd) 1 vial Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 1mg powder for solution for injection vials Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 1mg powder for solution for injection vials (Aspire Pharma Ltd) 1 vial Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 1mg powder for solution for injection vials Has active ingredient False Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 1mg powder for solution for injection vials (Aspire Pharma Ltd) Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 1mg powder for solution for injection vials 1 vial Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 2.5mg powder for solution for injection vials Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 2.5mg powder for solution for injection vials 1 vial Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 2.5mg powder for solution for injection vials Has active ingredient False Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 2.5mg powder for solution for injection vials (Aspire Pharma Ltd) Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 2.5mg powder for solution for injection vials (Aspire Pharma Ltd) 1 vial Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Velcade 3.5mg powder for solution for injection vials (Ortho Biotech) Has active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 3.5mg powder for solution for injection vials (Viatris UK Healthcare Ltd) Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 3.5mg powder for solution for injection vials (Viatris UK Healthcare Ltd) 1 vial Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 3.5mg powder for solution for injection vials (Accord Healthcare Ltd) 1 vial Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 3.5mg powder for solution for injection vials (Accord Healthcare Ltd) Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 3.5mg powder for solution for injection vials (Viatris UK Healthcare Limited) 1 vial (product) Has specific active ingredient False Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 3.5mg powder for solution for injection vials (Viatris UK Healthcare Limited) (product) Has specific active ingredient False Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 3.5mg powder for solution for injection vials (Zentiva Pharma UK Ltd) 1 vial Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 3.5mg powder for solution for injection vials (Zentiva Pharma UK Ltd) Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 3.5mg powder for solution for injection vials 1 vial Has active ingredient False Bortezomib Inferred relationship Existential restriction modifier
Velcade 3.5mg powder for solution for injection vials (Ortho Biotech) 1 vial Has active ingredient False Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 3.5mg powder for solution for injection vials (Tillomed Laboratories Ltd) 1 vial Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 3.5mg powder for solution for injection vials (Tillomed Laboratories Ltd) Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Velcade 3.5mg powder for solution for injection vials (Ortho Biotech) Has specific active ingredient False Bortezomib Inferred relationship Existential restriction modifier
Velcade 3.5mg powder for solution for injection vials (Ortho Biotech) 1 vial Has specific active ingredient False Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 3.5mg powder for solution for injection vials 1 vial Has specific active ingredient False Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 3.5mg lyophilized powder for injection Has specific active ingredient False Bortezomib Inferred relationship Existential restriction modifier
Velcade 3.5mg powder for solution for injection vials (Ortho Biotech) Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Velcade 3.5mg powder for solution for injection vials (Ortho Biotech) 1 vial Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 3.5mg powder for solution for injection vials 1 vial Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 3.5mg powder for solution for injection vials Has specific active ingredient True Bortezomib Inferred relationship Existential restriction modifier
Bortezomib 3.5mg powder for solution for injection vials Has active ingredient False Bortezomib Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start